Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Head-to-head · AI Drug Discovery Software

Recursion vs Boltzmann Labs

  • Updated Oct 2026
  • Both researched from official sources
  • 4 checks side by side
Higher score Recursion #3 in AI Drug Discovery Software 8.7/10 Pricing on request ✓ 3 of 4 features Visit Recursion
Boltzmann Labs #7 in AI Drug Discovery Software 7.7/10 Free plan Free plan✓ 2 of 4 features Visit Boltzmann Labs

Recursion leads on 0 checks, Boltzmann Labs on 1, and 3 are even. Who comes out ahead on the 4 yes/no, price and count checks where we have data for both products. The editor score weighs everything else too.

Our verdict

  • Highest scoreRecursion · 8.7/10
  • Free planonly Boltzmann Labs
  • Most featuresRecursion · 3 of 4

Recursion scores higher on our rubric for ai drug discovery software: 8.7 against 7.7 out of 10; our editors rank them #3 and #7.

Boltzmann Labs offers free plan; Recursion doesn't.

Recursion is the better fit for teams linking computational discovery to experiments. Boltzmann Labs is the better fit for teams wanting broad molecular design and prediction tools.

  • Recursion fits best

    Teams linking computational discovery to experiments

  • Boltzmann Labs fits best

    Teams wanting broad molecular design and prediction tools

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Side by side

Feature Recursion 8.7/10 Visit ↗ Boltzmann Labs 7.7/10 Visit ↗
At a glance
Editor score 8.7 7.7
Ranking #3 in AI Drug Discovery Software #7 in AI Drug Discovery Software
Best for Teams linking computational discovery to experiments Teams wanting broad molecular design and prediction tools
Pricing model Paid Free plan + paid
Starting price Pricing on request —
Free plan — ✓ (best)
Free trial — —
Built for Mid-market, Enterprise Small business, Mid-market, Enterprise
Features Recursion 3/4 · Boltzmann Labs 2/4
Target identification ✓ ✓
Molecule design ✓ ✓
Drug repurposing Not checked yet Not checked yet
Research publications ✓ (best) Not checked yet
Specs
Discovery scope Suite Suite
Deployment options Not checked yet Both
Our review
Pros
  • Connects target identification, molecule design and ADMET computation.
  • Combines machine-learning analysis of biological and chemical data.
  • Schedules synthesis and experiments, with results feeding computational workflows.
  • Covers small-molecule design, ADMET, docking and virtual screening
  • Includes protein, antibody, enzyme, peptide and RNA design tools
  • Offers web and API access, cloud or self-hosted deployment, and LIMS integration
Cons
  • No free plan is available.
  • Pricing is handled through sales rather than public plan tiers.
  • The proprietary Recursion OS is not open source.
  • Plan details are credit-based, with capabilities varying by plan
  • Enterprise credits are custom rather than a fixed amount
  • Published INR prices lack a billing period and billing unit
Our verdict

Recursion OS brings computational drug discovery and physical experimentation into one platform, with workflows that span target identification through molecule design and onward into development. Its capabilities include machine-learning…

Read the review →

Boltzmann Labs is a web-based AI drug discovery suite for pharmaceutical and biotechnology research teams seeking tools across molecular design and prediction. Its scope runs from small-molecule generation, lead optimization and ADMET…

Read the review →
  1. RecursionAI Drug Discovery Software 8.7Pricing on request
  2. Boltzmann LabsAI Drug Discovery Software 7.7Free plan

Strengths and trade-offs

  • Recursion — where it wins

    • Connects target identification, molecule design and ADMET computation.
    • Combines machine-learning analysis of biological and chemical data.
    • Schedules synthesis and experiments, with results feeding computational workflows.

    Where it doesn't

    • No free plan is available.
    • Pricing is handled through sales rather than public plan tiers.
    • The proprietary Recursion OS is not open source.

  • Boltzmann Labs — where it wins

    • Covers small-molecule design, ADMET, docking and virtual screening
    • Includes protein, antibody, enzyme, peptide and RNA design tools
    • Offers web and API access, cloud or self-hosted deployment, and LIMS integration

    Where it doesn't

    • Plan details are credit-based, with capabilities varying by plan
    • Enterprise credits are custom rather than a fixed amount
    • Published INR prices lack a billing period and billing unit

More comparisons

All AI drug discovery software comparisons → · Full ranking →

Guides on AI drug discovery software

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Last updated · How we research and update